Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Abeona Therapeutics Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 44 | 1 | 25 | −18 |
| SharesConverted for a 1-for-25 split | 837.1K | 516 | 1.19M | +356.9K (+42.7%) |
| Value | $4.51M | $3.00K | $3.62M | −$890.0K (−19.8%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Abeona Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 140,644 | $428.0K | 0.17% |
| Dimensional Fund Advisors LP | 33,983 | $103.0K | 0.00% |
| Barclays PLC | 3,660 | $11.0K | 0.00% |
| Group One Trading, L.P. | 3,497 | $11.0K | 0.00% |
Sold out (22)
Institutions that held Abeona Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 1,230,507 | $256.0K |
| Millennium Management LLC | 223,350 | $46.0K |
| Northern Trust Corp | 183,345 | $38.0K |
| Kore Private Wealth LLC | 154,637 | $32.0K |
| WS Management LLLP | 92,409 | $19.0K |
| Cedar Brook Financial Partners, LLC | 55,000 | $11.0K |
| Shay Capital LLC | 50,000 | $10.0K |
| Bank of New York Mellon Corp | 44,071 | $9.00K |
| UBS Group AG | 44,324 | $9.00K |
| M Holdings Securities, Inc. | 36,800 | $8.00K |
| Jane Street Group, LLC | 32,437 | $7.00K |
| Engineers Gate Manager LP | 22,385 | $5.00K |
| Victory Capital Management Inc | 18,992 | $4.00K |
| Boston Private Wealth LLC | 19,500 | $4.00K |
| WealthTrust Axiom LLC | 19,000 | $3.00K |
| Two Sigma Advisers, LP | 13,800 | $3.00K |
| Squarepoint Ops LLC | 14,197 | $3.00K |
| MML Investors Services, LLC | 10,000 | $2.00K |
| Bank of America Corp | 3 | $0 |
| Northwestern Mutual Wealth Management Co | 100 | $0 |
| Endurance Wealth Management, Inc. | 250 | $0 |
| Truvestments Capital LLC | 1,380 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Abeona Therapeutics Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| B. Riley Wealth Management, Inc. | 12,900 | $3.00K |